Discover the complete record of transactions filed by Divis Gregory J, 首席执行官. Officer active across 2 companies, notably Jaguar Health, Inc.. Aggregated, 2 filings have been recorded. Split: 1 buy · 0 sell. Total volume traded: €96k. Activity tracked since 27 May 2022. The latest transaction was filed on 27 May 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Gregory J Divis is the President and Chief Executive Officer of Jaguar Health, Inc. and AVADEL PHARMACEUTICALS PLC. He leads both companies and is responsible for their overall strategy. His leadership is essential for their growth.